Girdauskas, Evaldas
Pausch, Jonas
Reichenspurner, Hermann
Kempfert, Jörg
Kuntze, Thomas
Owais, Tamer
Holubec, Tomas
Krane, Markus
Vitanova, Keti
Borger, Michael
Eden, Matthias
Hachaturyan, Violetta
Bramlage, Peter
Falk, Volkmar
Clinical trials referenced in this document:
Documents that mention this clinical trial
Subannular repair for functional mitral regurgitation with reduced systolic ventricle function: rationale and design of REFORM-MR registry
https://doi.org/10.1186/s13019-022-02045-9
Subannular repair in secondary mitral regurgitation with restricted leaflet motion during systole
https://doi.org/10.1136/heartjnl-2022-322239
Funding for this research was provided by:
Edwards Lifesciences
Article History
Received: 25 March 2022
Accepted: 27 November 2022
First Online: 30 December 2022
Declarations
:
: The registry is established in accordance with the Declaration of Helsinki (1964) and was approved by the Ethics Committee of the Hamburg Medical Association (#PV5686) as well as the ethics committees responsible at each center. Patients provided written informed consent prior to the enrolment.
: Not applicable.
: EG: Received research funding for this registry and compensation for patient documentation and talks and advisory roles from Edwards Lifesciences (Nyon, Switzerland). JP: received compensation for patient documentation. HR: received compensation for patient documentation. JK: received compensation for patient documentation and talks and advisory roles from Edwards Lifesciences (Nyon, Switzerland). TK: received compensation for patient documentation. TO: received compensation for patient documentation. TH: received compensation for patient documentation. MK: received compensation for patient documentation. KV: received compensation for patient documentation. MB: received compensation for patient documentation and talks and advisory roles from Edwards Lifesciences (Nyon, Switzerland). ME: has no conflict to declare. VH: has no conflict to declare. PB: received research funding for this registry and compensation for talks and advisory roles from Edwards Lifesciences (Nyon, Switzerland). VF: received compensation for patient documentation and talks and advisory roles from Edwards Lifesciences (Nyon, Switzerland).